http://rdf.ncbi.nlm.nih.gov/pubchem/reference/204906027
Outgoing Links
| Predicate | Object |
|---|---|
| contentType | Journal Article |
| endingPage | 9 |
| issn | 1179-2043 1173-5503 |
| issueIdentifier | 1 |
| pageRange | 8-9 |
| publicationName | PharmacoEconomics & Outcomes News |
| startingPage | 8 |
| bibliographicCitation | Plosker GL. Risperidone. PharmacoEconomics & Outcomes News. 1994 Apr;3(1):8–9. doi: 10.1007/bf03289641. |
| creator | http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8588bebd7f8d15d5154ba1b374e5279d |
| date | 199404 |
| identifier | https://doi.org/10.1007/bf03289641 |
| isPartOf | https://portal.issn.org/resource/ISSN/1173-5503 https://portal.issn.org/resource/ISSN/1179-2043 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/49464 |
| language | English |
| source | https://www.crossref.org/ https://scigraph.springernature.com/ |
| title | Risperidone |
Total number of triples: 19.